-
digital.ahrq.gov/sites/default/files/docs/citation/state-regional-demonstration-hit-ut-final-report.pdf
November 01, 2015 - • Involving all stakeholders to provide input and direction regarding secondary use of
the information … There are many policies and procedures that are currently being created/updated
(e.g., consent, secondary
-
effectivehealthcare.ahrq.gov/health-topics/amyloidosis
-
hcup-us.ahrq.gov/reports/methods/2005_03_del_379.pdf
January 01, 2005 - the NHDS was as follows: if a symptom appeared
as a first-listed code and a diagnosis appeared as a secondary … If a symptom appeared as a first-
listed code and a diagnosis was
listed as a secondary code, the
diagnosis … NIS records to MedPAR data, only the NIS discharges for
which Medicare was the expected primary or secondary … For example, when a symptom appeared
as the first-listed code, the NHDS re-assigned the symptom as a secondary … either primary or
HCUP 2002 NIS (6/24/2005) 27 Deliverable #379: NIS Comparison Report, 2002
secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
July 01, 2009 - Questions centered on each stakeholder’s
current participation in distributed data networks, secondary … These restrictions and requirements are not unique to a DRN and would be
undertaken for any secondary … because they can use the network auditing
resources to manage all access and use of their data for secondary … The primary and secondary objectives of the proof-of-principle are described below. … made available to the authorized user
A log of site activity for each node is generated
The secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2011_research.pdf
January 01, 2011 - Secondary failure rates of measles vaccines:
a metaanalysis of published studies. … primary
Raynaud phenomenon: a meta-analysis of
the frequency, rates, and predictors of
transition to secondary … reporting
B Crude estimates Major flaw if C is not marked
C Authors reported estimates of primary
and secondary … applicable responses)
A Not reported Poor reporting
B Justified for primary outcome
C Justified for secondary … Not reported -0.07 0.13 0.09 0.08
Justified for primary outcome -0.02 0.97 0.95 0.05*
Justified for secondary
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2021_IP_MaskedStats.PDF
January 01, 2021 - POORLY DIFFERENT NEOPLASTIC DIAG
WITHOUT CC/MCC
165 0.00
846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS WITH MCC 155 0.00
847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC … 346 0.01
848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT
CC/MCC
23 0.00
849 … DIAGNOSIS WITH MCC 155 0.00
847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC … 346 0.01
848: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT
CC/MCC
23 0.00
849
-
hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2019_IP_MaskedStats.PDF
January 01, 2019 - MYELOPROLIF DIS OR POORLY DIFF NEOPL DIAG W/O CC/MCC 179 0.00
846: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY … DIAGNOSIS W MCC 126 0.00
847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 379 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 18 0.00
849: RADIOTHERAPY 26 … DIAGNOSIS W MCC 126 0.00
847: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W CC 379 0.01 … 848: CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS W/O CC/MCC 18 0.00
849: RADIOTHERAPY 26
-
www.ahrq.gov/patient-safety/settings/long-term-care/resource/ontime/prevhosp/ereportguide.html
September 01, 2017 - Discharge diagnoses from hospital (principal diagnosis and secondary diagnoses). … Discharge diagnoses from hospital (principal diagnosis and secondary diagnoses).
-
www.ahrq.gov/hai/cusp/toolkit/content-calls/briefing.html
April 01, 2013 - Is there a patient who requires my immediate attention secondary to acuity? … consistent care when our step-down unit was run by all nurse practitioners and the residents really played a secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_research-protocol.pdf
February 04, 2014 - subpopulations; and, finally, 4) whether there is more variation in patient outcomes with
any modality secondary … important harms or for certain
key questions when it is deemed at less risk for study limitations secondary
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs022670-patel-final-report-2019.pdf
January 01, 2019 - This will require the translation of easily available secondary data (e.g., EHR data logs, sensor-based … • Collecting secondary data from audit trails (unobtrusive and automated)
• Building support for data
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023875-kazemi-final-report-2018.pdf
January 01, 2018 - Alcohol use
among students also results in secondary effects on the campus environment7(30). … Secondary prevention with college
drinkers: Evaluation of an alcohol skills training program.
-
effectivehealthcare.ahrq.gov/sites/default/files/implementation-package-unhealthy-alcohol-use-final.pdf
September 01, 2018 - The Provider Guide for Addressing Unhealthy Alcohol Use
Secondary References:
4. … SECONDARY REFERENCES:
3. Cole, Stephen.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
November 20, 2013 - Four articles were secondary analyses of data initially
collected in RCTs; however, the secondary analyses
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - storage disorders (LSD)
comprise a group of unique monogenic autosomal or
X-linked diseases that occur secondary … The text was revised to read as follows: “Most
LSD patients present with symptoms secondary to
existing … Secondary endpoints of the phase II/III clinical trial are not
included
Please populate the columns … ERT does not cross the
blood-brain barrier, and therefore, has no cognitive benefits,
except for secondary … cognitive function” perhaps could have been the result
of fatigue, or a decrement in physical function
secondary
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
March 01, 2012 - Relative to effectiveness of each of the three
prophylaxis regimens, secondary observations include; … Studies
Efficacy Outcomes
Primary Efficacy Outcome
● DVT, non-fatal PE, all-cause mortality
Main Secondary … They reported on
primary and secondary diagnosis and did not analyze
orthopedic surgery specifically … The focus of this CER was not secondary
prevention therefore outcomes such as recurrent VTE were not … DVTs occur at a higher rate than PEs as primary and
secondary diagnoses.
-
digital.ahrq.gov/sites/default/files/docs/patient-centered-care-transcript-033011.pdf
June 16, 2021 - Our main outcome measure is hemoglobin
A1c, and other secondary measures include blood pressure and … of moving directly into the field trial of this
commercial PHR we would instead move up one of our secondary
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/tobacco-use-in-adults-and-pregnant-women-counseling-and-interventions
January 19, 2021 - E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis … secondary analyses of a randomised controlled trial. … Across all 7 trials, there was mixed evidence on secondary process outcomes such as documentation of
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - trials that were designed and powered to demonstrate invasive breast cancer incidence as a primary or secondary … For raloxifene, breast cancer incidence was a primary outcome in RUTH and a secondary outcome in MORE … & Developed using secondary data sources with inadequate description of the population and duration
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
September 01, 2017 - each method
First Author Publication
Year
Drug RoB 1 Size
(n)
Primary reason
to include:
Secondary … if they compared 2
or more drugs of interest: nonrandomized controlled
trials, open- label trials, secondary … double-blind RCTs, recent
systematic reviews, nonrandomized controlled trials,
open-label trials, secondary